Edge Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-500	Closed	-$5K	–	424
2013 Q4	$5K	Sell	500 -2,500	-83%	-$25K	﹤0.01%	294
2013 Q3	$34K	Buy	+3,000	New	+$34K	0.02%	163